Health Condition 1: E785- Hyperlipidemia, unspecified
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
Dr Reddys Laboratories Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1 Electronic medical data of Patients with a confirmed diagnosis (either by angiography or clinical findings) of the first ACS event (STEMI [ST elevation myocardial infarction]/NSTEMI [non-ST elevation myocardial infarction]/ unstable angina) 2 Minimum of 12 months of follow-up data post statin therapy initiation 3 Patients initiated statin therapy prior to or post first ACS event 4 Patients considered for initiation/ maintenance/ modification of statin therapy before discharge from hospital
Exclusion criteria
Exclusion criteria: EMR of Patients with a history of hospital admission for ACS in the past 12 months before the index event , type 1 diabetes mellitus, history of malignancy, patients with active or suspected or with history of hepatic or stage 5 renal disease, history of uncontrolled hypothyroidism, alcohol, or drug abuse, Patients on hormone replacement therapy or oral contraceptives within 3 months of enrollment or pregnant patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1 The dose of statin/statin plus other lipid-lowering therapies after the first ACS event at discharge and the end of 12 months 2 The proportion of patients with a history of dyslipidemia and first ACS event and the dose of statins/statin plus other lipid-lowering therapies during/before the event, at discharge and the end of 12 monthsTimepoint: Baseline and 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 percentage of patients with co-morbid conditions and risk factors stratified by age and sex 2 Utilization pattern of statin/statin plus other lipid-lowering therapy in dyslipidemia patients with first ACS event and having comorbidities 3 Incidence rates of recurrent ACS, stroke, heart failure, revascularization, and cardiovascular-specific deaths reportedTimepoint: Baseline or discharge from hospital and end of 12 months | — |
Countries
India
Contacts
Public ContactDr Rahul Rathod
Dr Reddys Laboratories ltd
Outcome results
None listed